Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

Jose M. Munita; Nagendra N. Mishra; Danya Alvarez; Truc T. Tran; Lorena Diaz; Diana Panesso; Jinnethe Reyes; Barbara E. Murray; Javier A. Adachi; Arnold S. Bayer; Cesar A. Arias

doi:10.1093/cid/ciu642

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

Jose M. Munita
, Nagendra N. Mishra
, Danya Alvarez
, Truc T. Tran
, Lorena Diaz
, Diana Panesso
, Jinnethe Reyes
, Barbara E. Murray
, Javier A. Adachi
, Arnold S. Bayer
, Cesar A. Arias

Division of Infectious Diseases
Universidad del Desarrollo
University of California at Los Angeles
The Lundquist Institute
Universidad El Bosque
University of Texas Medical School at Houston
MD Anderson Cancer Center

Producción: Contribución a una revista › Artículo › revisión exhaustiva

57 Citas (Scopus)

Resumen

High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.

Idioma original	Inglés
Páginas (desde-hasta)	1277-1280
Número de páginas	4
Publicación	Clinical Infectious Diseases
Volumen	59
N.º	9
DOI	https://doi.org/10.1093/cid/ciu642
Estado	Publicada - 01 nov 2014
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1093/cid/ciu642

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

Munita, J. M., Mishra, N. N., Alvarez, D., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., Adachi, J. A., Bayer, A. S., & Arias, C. A. (2014). Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions. Clinical Infectious Diseases, 59(9), 1277-1280. https://doi.org/10.1093/cid/ciu642

@article{ba0c8e482ad64545bca097dc757c0455,

title = "Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions",

abstract = "High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.",

keywords = "Daptomycin, Enterococcus faecium, resistance, treatment failure",

author = "Munita, \{Jose M.\} and Mishra, \{Nagendra N.\} and Danya Alvarez and Tran, \{Truc T.\} and Lorena Diaz and Diana Panesso and Jinnethe Reyes and Murray, \{Barbara E.\} and Adachi, \{Javier A.\} and Bayer, \{Arnold S.\} and Arias, \{Cesar A.\}",

note = "Publisher Copyright: {\textcopyright} 2014 The Author.",

year = "2014",

month = nov,

day = "1",

doi = "10.1093/cid/ciu642",

language = "English",

volume = "59",

pages = "1277--1280",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

AU - Munita, Jose M.

AU - Mishra, Nagendra N.

AU - Alvarez, Danya

AU - Tran, Truc T.

AU - Diaz, Lorena

AU - Panesso, Diana

AU - Reyes, Jinnethe

AU - Murray, Barbara E.

AU - Adachi, Javier A.

AU - Bayer, Arnold S.

AU - Arias, Cesar A.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.

AB - High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.

KW - Daptomycin

KW - Enterococcus faecium

KW - resistance

KW - treatment failure

UR - https://www.scopus.com/pages/publications/84907049035

U2 - 10.1093/cid/ciu642

DO - 10.1093/cid/ciu642

M3 - Article

C2 - 25107294

AN - SCOPUS:84907049035

SN - 1058-4838

VL - 59

SP - 1277

EP - 1280

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 9

ER -

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto